top of page
Search

The Two Classes of Biological Weapons: Those that Kill, those that Incapacitate

Updated: Dec 16, 2023

By: A. W. Finnegan





Leptospira spirochetes as incapacitating antipersonnel biological weapons
Leptospira spirochetes, an incapacitating agent

In my newly released book, The Sleeper Agent: The Rise of Lyme Disease, Chronic Illness, and the Great Imitator Antigens of Biological Warfare, I document and initiate the reader into the esoteric history and science of stealth biological weapons that cause the dark triad of chronic disease, mental illness, and cancer, used as strategic biological weapons that incapacitate, tire, exhaust, overwhelm, and demoralize the enemy slowly over time.


Where these are used, the effects are not easily apparent and slowly gain momentum over the course of months to years and gain steady momentum over subsequent decades. They are usually not discovered until it is far too late, when the disease has progressed to a stage that is so resistant it is nearly incurable. The symptoms are very confusing to diagnose as they mimic other common diseases, the course of disease in each person will unravel in infinite variation between cases and the combination of many disease agents can make both diagnosis and treatment nearly impossible. Typically, these agents target and destroy the immune system and because of this, the disease plays out in a unique way for each person afflicted.


While this class of biological weapons is not directly fatal in the short-term, in the long-term they can be fatal indirectly because they can cause cancer and mental illness, which can bring murder and suicide, both of which can lead to far more death than those agents that quickly kill but burn themselves out equally as fast. In the slow-acting incapacitating agents, infection rates can be far higher than the fast-acting, fatal agents, and more systemically proliferate the population. This is especially so when they are harder to discover and diagnose. These agents are also very burdensome to the economy of any nation, because unemployment skyrockets, the public health system cannot adequately address the confusing mystery diseases and it overwhelms the healthcare and medical system. The cost of treating or managing such diseases is complicated and very expensive.


Typically, when a person thinks of biological warfare and its uses, they tend to imagine only the class of biological weapons that produce fatal and immediate damage as the only kind of biological weapons that would make any sense. But this is because they are not aware of all the intricacies and underlying factors that surround such weapons banned by international treaties, nor are they aware at all of the challenges using such weapons and what the risk of getting caught presents to the attacking nation.


I will try to clarify and educate the reader to show why effective attacks with biological weapons are more costly and effective in the long-term using slow-acting non-fatal biological weapons (strategic bioweapons) are vs. the quick-acting and fatal biological weapons (tactical bioweapons) which are easier to spot, contain the outbreak, and potentially trace the agent back to the attacking nation.


In typical fashion, the classic response to the possibility of strategic, non-fatal infections like Lyme disease or slow-virus diseases like Human Immunodeficiency Virus (HIV), I repeatedly see this response to discredit the idea that such diseases could be used as biological weapons:


"Why would anyone develop a bioweapon that can take years to incubate or show symptoms? Sorry, not likely a bioweapon..."

In a 1969 congressional hearing, the effects of the slow-incubating, immune-damaging incapacitating biological weapons are laid bare by General Douglas MacArthur:


Within the next 5 to 10 years, it would probably be possible to make a new infective microorganism which could differ in certain important aspects from any known disease-causing organisms. Most important of these is that it might be refractory to the immunological and therapeutic processes upon which we depend to maintain our relative freedom from infectious disease.


This same class of biological weapons were listed as economic weapons by an assessment given to the Central Intelligence Agency, called “The Darker Bioweapons Future” showing the threat of such weapons, sometimes delivered as binary components from separate sources, being used as economic weapons and leaving a large portion of civilians in their adult life too sick to work:

According to the scientists convened, other classes of unconventional pathogens that may arise over the next decade and beyond include binary BW agents that only become effective when two components are combined (a particularly insidious example would be a mild pathogen that when combined with its antidote becomes virulent); “designer” BW agents created to be antibiotic resistant or to evade an immune response; weaponized gene therapy vectors that effect permanent change in the victim’s genetic makeup; or a “stealth” virus, which could lie dormant inside the victim for an extended period before being triggered. For example, one panelist cited the possibility of a stealth virus attack that could cripple a large portion of people in their forties with severe arthritis, concealing its hostile origin and leaving a country with massive health and economic problems.


In my recent book, The Sleeper Agent: The Rise of Lyme Disease, Chronic Illness, and the Great Imitator Antigens of Biological Warfare, the science and history of these incapacitating agents that cause chronic diseases, mental illness, and cancers is discussed in great depth, especially the pioneer of immunological weapons, Dr. Erich Traub, and his discovery of the resistant condition left in its wake, called immune tolerance.


Buy your copy of The Sleeper Agent: The Rise of Lyme Disease, Chronic Illness, and the Great Imitator Antigens of Biological Warfare, here: https://www.thesleeperagent.com/product-page/the-sleeper-agent




31 views0 comments

Comments


Commenting has been turned off.
bottom of page